参考文献/References:
[1] Chaudhry MA. Radiation-induced microRNA:discovery, functional analysis, and cancer radiotherapy[J]. J Cell Biochem, 2014, 115(3):436-449. DOI:10. 1002/jcb. 24694.
[2] Zhao L, Bode AM, Cao Y, et al. Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity[J]. Carcinogenesis, 2012, 33(11):2220-2227. DOI:10. 1093/carcin/bgs235.
[3] Zhao L, Lu X, Cao Y. MicroRNA and signal transduction pathways in tumor radiation response[J]. Cell Signal, 2013, 25(7):1625-1634. DOI:10. 1016/j. cellsig. 2013. 04. 004.
[4] Tong AW, Nemunaitis J. Modulation of miRNA activity in human cancer:a new paradigm for cancer gene therapy?[J]. Cancer Gene Ther, 2008, 15(6):341-355. DOI:10. 1038/cgt. 2008. 8.
[5] Griveau A, Bejaud J, Anthiya S, et al. Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death[J]. Int J Pharm, 2013, 454(2):765-774. DOI:10. 1016/j. ijpharm. 2013. 05. 049.
[6] Huang S, Li XQ, Chen X, et al. Inhibition of microRNA-21 increases radiosensitivity of esophageal cancer cells through phosphatase and tensin homolog deleted on chromosome 10 activation[J]. Dis Esophagus, 2013, 26(8):823-831. DOI:10. 1111/j. 1442-2050. 2012. 01389. x.
[7] 狄英波, 薛茗方, 刘雅娟, 等. miR-21在辐射敏感性不同的3种乳腺癌细胞株中的表达差异及意义[J]. 中国妇幼保健, 2013, 28(9):1499-1501. DOI:10. 7620/zgfybj. j. issn. 1001-4411. 2013.28.43. Di YB, Xue MF, Liu YJ, et al. Differences and significances of miR-21 expressions in three kinds of breast cancer cell strains of different radiative sensitivities[J]. Matern Child Health Care China, 2013, 28(9):1499-1501.
[8] Anastasov N, H?fig I, Vasconcellos IG, et al. Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells[J]. Radiat Oncol, 2012, 7(20):206. DOI:10. 1186/1748-717X-7-206.
[9] Huang X, Ding L, Bennewith KL, et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation[J]. Mol Cell, 2009, 35(6):856-867. DOI:10. 1016/j. molcel. 2009. 09. 006.
[10] Karar J, Maity A. Modulating the tumor microenvironment to increase radiation responsiveness[J]. Cancer Biol Ther, 2009, 8(21):1994-2001.
[11] Yang W, Sun T, Cao J, et al. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro[J]. Exp Cell Res, 2012, 318(8):944-954. DOI:10. 1016/j. yexcr. 2012. 02. 010.
[12] Yang W, Wei J, Sun T, et al. Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice[J]. Radiat Oncol, 2013, 8(2):102. DOI:10. 1186/1748-717X-8-102.
[13] Grosso S, Doyen J, Parks SK, et al. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines[J/OL]. Cell Death Dis, 2013, 4(3):e544[2015-10-20]. http://www.nature.com/cddis/journal/v4/n3/full/cddis201371a.html. DOI:10.1038/cddis.2013.71.
[14] Cheng HY, Obrietan K. Revealing a role of microRNAs in the regulation of the biological clock[J]. Cell Cycle, 2007, 6(24):3034-3035.
[15] Ciafrè SA, Galardi S, Mangiola A, et al. Extensive modulation of a set of microRNAs in primary glioblastoma[J]. Biochem Biophys Res Commun, 2005, 334(4):1351-1358. DOI:10. 1016/j. bbrc. 2005. 07. 030.
[16] Gramantieri L, Fornari F, Ferracin M, et al. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality[J]. Clin Cancer Res, 2009, 15(16):5073-5081. DOI:10. 1158/1078-0432. CCR-09-0092.
[17] Koelz M, Lense J, Wrba F, et al. Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors[J]. Int J Oncol, 2011, 38(2):503-511. DOI:10. 3892/ijo. 2010. 857.
[18] Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues[J]. Oncogene, 2006, 25(17):2537-2545. DOI:10. 1038/sj. onc. 1209283.
[19] Gottardo F, Liu CG, Ferracin M, et al. Micro-RNA profiling in kidney and bladder cancers[J]. Urol Oncol, 2007, 25(5):387-392. DOI:10. 1016/j. urolonc. 2007. 01. 019.
[20] He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma[J]. Proc Natl Acad Sci USA, 2005, 102(52):19075-19080. DOI:10. 1073/pnas. 0509603102.
[21] Lee EJ, Gusev Y, Jiang J, et al. Expression profiling identifies microRNA signature in pancreatic cancer[J]. Int J Cancer, 2007, 120(5):1046-1054. DOI:10. 1002/ijc. 22394.
[22] Vlachos P, Joseph B. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics[J]. Oncogene, 2009, 28(47):4175-4188. DOI:10. 1038/onc. 2009. 269.
[23] Chun-Zhi Z, Lei H, An-Ling Z, et al. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN[J]. BMC Cancer, 2010, 10:367. DOI:10. 1186/1471-2407-10-367.
[24] 张晓槟. 反义microRNA-221对结直肠癌细胞放射敏感性的影响及相关机制[D]. 广州:南方医科大学, 2013. Zhang XB. Effect of antisense microRNA-221 on radiation sensitivity of colorectal cancer cells and the underlying mechanism[D]. Guangzhou:Southern Medical University, 2013.
[25] Bargaje R, Hariharan M, Scaria V, et al. Consensus miRNA expression profiles derived from interplatform normalization of microarray data[J]. RNA, 2010, 16(1):16-25. DOI:10. 1261/rna. 1688110.
[26] Yue J, Tigyi G. Conservation of miR-15a/16-1 and miR-15b/16-2 clusters[J]. Mamm Genome, 2010, 21(1/2):88-94. DOI:10. 1007/s00335-009-9240-3.
[27] Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2[J]. Proc Natl Acad Sci USA, 2005, 102(39):13944-13949. DOI:10. 1073/pnas. 0506654102.
[28] Bottoni A, Piccin D, Tagliati F, et al. miR-15a and miR-16-1 down-regulation in pituitary adenomas[J]. J Cell Physiol, 2005, 204(1):280-285. DOI:10. 1002/jcp. 20282.
[29] Bonci D, Coppola V, Musumeci M, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities[J]. Nat Med, 2008, 14(11):1271-1277. DOI:10. 1038/nm. 1880.
[30] Calin GA, Cimmino A, Fabbri M, et al. MiR-15a and miR-16-1 cluster functions in human leukemia[J]. Proc Natl Acad Sci USA, 2008, 105(13):5166-5171. DOI:10. 1073/pnas. 0800121105.
[31] Tsang TY, Tang WY, Chan JY, et al. P-glycoprotein enhances radiation-induced apoptotic cell death through the regulation of miR-16 and Bcl-2 expressions in hepatocellular carcinoma cells[J]. Apoptosis, 2011, 16(5):524-535. DOI:10.1007/s10495-011-0581-5.
[32] 刘琴. miR-16家族在肿瘤细胞周期调控中的作用研究[D]. 北京:中国人民解放军军事医学科学院, 2008. Liu Q. Function research of miR-16 family on tumer cell cycle regulation[D]. Beijing:Academy of Military Medical Sciences, 2008.
[33] Mei Z, Su T, Ye J, et al. The miR-15 family enhances the radiosensitivity of breast cancer cells by targeting G2 checkpoints[J]. Radiat Res, 2015, 183(2):196-207. DOI:10. 1667/RR13784. 1.
[34] Shingara J, Keiger K, Shelton J, et al. An optimized isolation and labeling platform for accurate microRNA expression profiling[J]. RNA, 2005, 11(9):1461-1470. DOI:10. 1261/rna. 2610405.
[35] Zhang P, Wang L, Rodriguez-Aguayo C, et al. miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13[J]. Nat Commun, 2014, 5:5671. DOI:10.1038/ncomms6671.
[36] Zhang P, Wei Y, Wang L, et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1[J]. Nat Cell Biol, 2014, 16(9):864-875. DOI:10. 1038/ncb3013.
[37] He L, He XY, Lim LP, et al. A microRNA component of the p53 tumour suppressor network[J]. Nature, 2007, 447(7148):1130-1134. DOI:10. 1038/nature05939.
[38] Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis[J]. Mol Cell, 2007, 26(5):731-743. DOI:10. 1016/j. molcel. 2007. 05. 017.
[39] Chang TC, Wentzel EA, Kent OA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis[J]. Mol Cell, 2007, 26(5):745-752. DOI:10. 1016/j. molcel. 2007. 05. 010.
[40] Tazawa H, Tsuchiya N, Izumiya M, et al. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells[J]. Proc Natl Acad Sci USA, 2007, 104(39):15472-15477. DOI:10. 1073/pnas. 0707351104.
[41] Corney DC, Flesken-Nikitin A, Godwin AK, et al. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth[J]. Cancer Res, 2007, 67(18):8433-8438. DOI:10. 1158/0008-5472. CAN-07-1585.
[42] Tarasov V, Jung P, Verdoodt B, et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing:miR-34a is a p53 target that induces apoptosis and G1-arrest[J]. Cell Cycle, 2007, 6(13):1586-1593.
[43] Bommer GT, Gerin I, Feng Y, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes[J]. Curr Biol, 2007, 17(15):1298-1307. DOI:10. 1016/j. cub. 2007. 06. 068.
[44] Maki Y, Asano H, Toyooka S, et al. MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells[J]. Anticancer Res, 2012, 32(11):4871-4875.
[45] Thornton JE, Gregory RI. How does Lin28 let-7 control development and disease?[J]. Trends Cell Biol, 2012, 22(9):474-482. DOI:10. 1016/j. tcb. 2012. 06. 001.
[46] Rao L, Huang X, Xu S. Molecular mechanism and related influence factors of Lin28/Let-7 axsis[J]. J Clin Otorhinolaryngol Head Neck Surgery, 2014, 28(9):663-665.
[47] Wang L, Yuan C, Lv K, et al. Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A. X and Let-7 signaling[J/OL]. PLoS One, 2013, 8(6):e67373[2016-10-20]. https://www.ncbi.nlm.nih.gov/pubmed/?term=23840685. DOI:10.1371/journal. pone. 0067373.
[48] Arora H, Qureshi R, Jin S, et al. miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFκB1[J]. Exp Mol Med, 2011, 43(5):298-304. DOI:10.3858/emm.2011.43.5.031.
相似文献/References:
[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[3]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[4]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[5]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[6]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[7]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[8]段永璇,邹晓艳,段秀梅,等.数据解析在肿瘤放射治疗中的应用[J].国际放射医学核医学杂志,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
Duan Yongxuan,Zou Xiaoyan,Duan Xiumei,et al.Data analysis in the field of tumor radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
[9]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
[10]曹婉婷,李浣洋,陈雪英,等.正常组织在放射治疗中并发的迟发性损伤[J].国际放射医学核医学杂志,2015,39(3):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
Cao Wanting,Li Huanyang,Chen Xueying,et al.Late effects of radiotherapy on normal tissue[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
[11]周冲,王利利,周菊英.微小RNAs在分子放射生物学中的研究进展[J].国际放射医学核医学杂志,2009,33(2):109.[doi:10.3760/cma.j.issn.1673-4114.2009.02.014]
ZHOU Chong,WANG Li-li,ZHOU Ju-ying.Progress of microRNAs in molecular radiobiology[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):109.[doi:10.3760/cma.j.issn.1673-4114.2009.02.014]